Edesa Biotech earnings were -$7.2M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest EDSA earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$2.2M, up 27.4% from last quarter. For the last reported fiscal year 2025 ending Sep 30, 2025, EDSA reported annual earnings of -$7.2M, with 16.5% growth.
Edesa Biotech (NASDAQ: EDSA) reported Q3 2025 earnings per share (EPS) of -$0.32, up 10.34% year over year. Total EDSA earnings for the quarter were -$2.23 million. In the same quarter last year, Edesa Biotech's earnings per share (EPS) was -$0.29.
As of the last Edesa Biotech earnings report, Edesa Biotech is currently losing money. Edesa Biotech's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$7.19 million, a 16.46% increase year over year.
What was EDSA's earnings growth in the past year?
As of Edesa Biotech's earnings date in Q1 2026, Edesa Biotech's earnings has grown year over year. EDSA earnings in the past year totalled -$7.19 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.